|
Dr. Stockwell is one of the scientific co-founders of CombinatoRx. Dr. Stockwell's research at Columbia involves application of chemical genetics to the study of orphan genetic diseases, including sarcomas, spinal muscular atrophy and Huntington's disease. Prior to joining the faculty of Columbia University, he was a fellow at the Whitehead Institute for Biomedical Research, where he developed new tools for chemical genetics and identified novel compounds with relevance to cancer and neurodegeneration. Dr. Stockwell studied organic chemistry and molecular biology during his graduate training under Stuart L. Schreiber in the Department of Chemistry and Chemical Biology at Harvard University. While at Harvard, he was awarded National Science Foundation and Howard Hughes Medical Institute Pre-doctoral Fellowships, and a number of teaching awards. Dr. Stockwell received his A.B. degree from Cornell University, graduating Summa cum Laude with membership in Phi Beta Kappa and a dual major in chemistry and economics. In 2002, he was awarded a Career Award at the Scientific Interface from the Burroughs Wellcome Fund for his interdisciplinary research. | 